---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-23-008082"
form_type: "8-K"
ticker: "ASPI"
cik: "0001921865"
company_name: "ASP Isotopes Inc."
filed_at: "2023-11-03T23:59:59+00:00"
generated_at: "2026-06-08T22:46:03.010844+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ASP Isotopes to acquire 51% of PET Labs for $2M; plans two new cyclotrons with GE Healthcare

## Summary
- Acquired 51% of PET Labs for $2M; option to buy remaining 49% for $2.2M by Jan 2027.
- Strategic relationship to produce and distribute medical isotopes in frontier markets using cyclotrons.
- Plans to add two GE Healthcare cyclotrons in Pretoria and Cape Town, financed by third-party debt.
- PET Labs currently operates one cyclotron in Pretoria, expanding radioisotope production.

## SEC filing metadata
- accession: 0001477932-23-008082
- form_type: 8-K
- ticker: ASPI
- cik: 0001921865
- company_name: ASP Isotopes Inc.
- filed_at: 2023-11-03T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1921865/000147793223008082/0001477932-23-008082-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1921865/000147793223008082/aspi_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-23-008082
- JSON: https://secwatch.observer/filing/0001477932-23-008082.json
- Plain text: https://secwatch.observer/filing/0001477932-23-008082.txt

## Key facts
- Material Agreements
  ASP Isotopes Inc. entered into Share Purchase Agreement with Nucleonics Imaging Proprietary Limited valued at USD 2,000,000 for 51% of PET Labs shares, with option for remaining 49% for USD 2,200,000 (effective 2023-10-30).
  - Action: entry
  - Agreement: asset purchase
  - Counterparty: Nucleonics Imaging Proprietary Limited
  - Value: USD 2,000,000 for 51% of PET Labs shares, with option for remaining 49% for USD 2,200,000
  - Effective: 2023-10-30
  source text: On October 30, 2023, ASP Isotopes Inc. (the “Company”) entered into a Share Purchase Agreement (the “Purchase Agreement”) with Nucleonics Imaging Proprietary Limited, a company incorporated in the Republic of South Africa (“Seller”), relating to the purchase and sale of ordinary shares in the issued share capital of Pet Labs Pharmaceuticals Proprietary Limited, a company incorporated in the Republic of South Africa (“PET Labs”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1921865/000147793223008082/0001477932-23-008082-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.